Nora T Oliver1, Elizabeth Y Chiao. 1. aDepartment of Medicine, Section of Infectious Diseases, Atlanta VA Medical Center, Decatur, Georgia bDepartment of Medicine, Section of Infectious Diseases and Health Services Research, Baylor College of Medicine, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: To review current knowledge of different cancer states affecting women with HIV infection. RECENT FINDINGS: With improved survival of persons with HIV in the post-cART era, the landscape of malignancies in this population has greatly changed with fewer AIDS-defining malignancies (ADM) and a growing number of non-AIDS defining malignancies (NADM). Women, however, continue to represent a vulnerable population at risk for certain ADM and NADM such as cervical, anal, and breast cancer. Human papillomavirus-mediated cancers disproportionately burden women in resource-poor settings such as sub-Saharan Africa. For cancers such as Kaposi's sarcoma, lung cancer, liver cancer, and colorectal cancer, women share a lower burden of disease compared with their male counterparts. However, there remains a dearth of evidence characterizing these disease states specifically among women. SUMMARY: Cancer in women with HIV continues to be a major source of morbidity and mortality worldwide, especially in low-income countries. Screening strategies, primary prevention through vaccination against human papillomavirus and viral hepatitis, and treatment for HIV with combined antiviral therapy remain cornerstones in cancer prevention.
PURPOSE OF REVIEW: To review current knowledge of different cancer states affecting women with HIV infection. RECENT FINDINGS: With improved survival of persons with HIV in the post-cART era, the landscape of malignancies in this population has greatly changed with fewer AIDS-defining malignancies (ADM) and a growing number of non-AIDS defining malignancies (NADM). Women, however, continue to represent a vulnerable population at risk for certain ADM and NADM such as cervical, anal, and breast cancer. Humanpapillomavirus-mediated cancers disproportionately burden women in resource-poor settings such as sub-Saharan Africa. For cancers such as Kaposi's sarcoma, lung cancer, liver cancer, and colorectal cancer, women share a lower burden of disease compared with their male counterparts. However, there remains a dearth of evidence characterizing these disease states specifically among women. SUMMARY:Cancer in women with HIV continues to be a major source of morbidity and mortality worldwide, especially in low-income countries. Screening strategies, primary prevention through vaccination against human papillomavirus and viral hepatitis, and treatment for HIV with combined antiviral therapy remain cornerstones in cancer prevention.
Authors: Basil F El-Rayes; Kambeez Berenji; Paula Schuman; Philip A Philip; Kambeez Barenji Journal: Breast Cancer Res Treat Date: 2002-11 Impact factor: 4.872
Authors: J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar Journal: Lancet Date: 1998-06-20 Impact factor: 79.321
Authors: Victoria M Youngblood; Ruth Nyirenda; Richard Nyasosela; Takondwa Zuze; Yi Yang; Evaristar Kudowa; Agnes Moses; Jennifer Kincaid; Chifundo Kajombo; Coxcilly Kampani; Fred Chimzimu; Maurice Mulenga; Chrissie Chilima; Grace K Ellis; Ryan Seguin; Maganizo Chagomerana; Rebecca Maine; Sheryl Jordan; Anthony Charles; Clara Lee; Satish Gopal; Tamiwe Tomoka Journal: Cancer Causes Control Date: 2020-03-02 Impact factor: 2.506
Authors: Eva Clark; Liang Chen; Yongquan Dong; Suchismita Raychaudhury; Donna White; Jennifer R Kramer; Elizabeth Chiao Journal: Clin Infect Dis Date: 2021-05-04 Impact factor: 9.079
Authors: Robin T Higashi; Serena A Rodriguez; Andrea C Betts; Jasmin A Tiro; Amneris E Luque; Rachel Rivera; Arti Barnes Journal: AIDS Care Date: 2021-02-17
Authors: Sally B Coburn; Meredith S Shiels; Michael J Silverberg; Michael A Horberg; M John Gill; Todd T Brown; Kala Visvanathan; Avonne E Connor; Sonia Napravnik; Julia L Marcus; Richard D Moore; W Chris Mathews; Angel M Mayor; Timothy R Sterling; Jun Li; Charles S Rabkin; Gyspyamber D'Souza; Bryan Lau; Keri N Althoff Journal: J Acquir Immune Defic Syndr Date: 2021-05-01 Impact factor: 3.771
Authors: Missak Haigentz; Page Moore; Milan Bimali; Timothy Cooley; Joseph Sparano; Michelle Rudek; Lee Ratner; David Henry; Juan Ramos; John Deeken; Paul Rubinstein; Elizabeth Chiao Journal: Oncologist Date: 2022-08-05 Impact factor: 5.837